Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antibody-drug conjugates or ADCs are a class of biological drugs designed as targeted therapies for cancer treatment. Unlike chemotherapy, ADC is designed to target and kill tumor cells while preserving healthy cells.
By 2030, its compound annual growth rate (CAGR) will grow by more than 20% due to its growing popularity and therapeutic potential. ADC has six commercially available drugs, which are currently considered to be effective targeted anti-cancer therapies with potential for the treatment of many other diseases. The analysis said that the success of such products can be attributed to their ability to effectively identify and eliminate disease-related cells/pathogens, while the risk of side effects related to treatment is greatly reduced.
Antibody drug conjugates are currently considered to be effective targeted anti-cancer therapies, which will lead to market growth. The increase in the number of cancers has promoted the development of the market. The government and medical institutions have increased investment in research and development of antibody-drug conjugates, which has promoted the further expansion of the market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antibody-drug Conjugates market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antibody-drug Conjugates market. Detailed analysis of key players, along with key growth strategies adopted by Antibody-drug Conjugates industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Roche
Seattle Genetics
Takeda
ImmunoGen
By Type:
Adcetris
Kadcyla
By End-User:
Breast Cancer
Lymphoma
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antibody-drug Conjugates Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antibody-drug Conjugates Market Size and Growth Rate of Adcetris from 2016 to 2027
-
1.3.2 USA Antibody-drug Conjugates Market Size and Growth Rate of Kadcyla from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.2 USA Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antibody-drug Conjugates Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antibody-drug Conjugates by Major Types
-
3.4.1 Market Size and Growth Rate of Adcetris
-
3.4.2 Market Size and Growth Rate of Kadcyla
4 Segmentation of Antibody-drug Conjugates Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antibody-drug Conjugates by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antibody-drug Conjugates in Breast Cancer
-
4.4.2 Market Size and Growth Rate of Antibody-drug Conjugates in Lymphoma
5 Market Analysis by Regions
-
5.1 USA Antibody-drug Conjugates Production Analysis by Regions
-
5.2 USA Antibody-drug Conjugates Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antibody-drug Conjugates Landscape Analysis
-
6.1 West USA Antibody-drug Conjugates Landscape Analysis by Major Types
-
6.2 West USA Antibody-drug Conjugates Landscape Analysis by Major End-Users
7 South USA Antibody-drug Conjugates Landscape Analysis
-
7.1 South USA Antibody-drug Conjugates Landscape Analysis by Major Types
-
7.2 South USA Antibody-drug Conjugates Landscape Analysis by Major End-Users
8 Middle West USA Antibody-drug Conjugates Landscape Analysis
-
8.1 Middle West USA Antibody-drug Conjugates Landscape Analysis by Major Types
-
8.2 Middle West USA Antibody-drug Conjugates Landscape Analysis by Major End-Users
9 Northeast USA Antibody-drug Conjugates Landscape Analysis
-
9.1 Northeast USA Antibody-drug Conjugates Landscape Analysis by Major Types
-
9.2 Northeast USA Antibody-drug Conjugates Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Roche
-
10.1.1 Roche Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Seattle Genetics
-
10.2.1 Seattle Genetics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Takeda
-
10.3.1 Takeda Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 ImmunoGen
-
10.4.1 ImmunoGen Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antibody-drug Conjugates Market Size and Growth Rate of Adcetris from 2016 to 2027
-
Figure USA Antibody-drug Conjugates Market Size and Growth Rate of Kadcyla from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antibody-drug Conjugates Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antibody-drug Conjugates
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antibody-drug Conjugates by Different Types from 2016 to 2027
-
Table Consumption Share of Antibody-drug Conjugates by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Adcetris
-
Figure Market Size and Growth Rate of Kadcyla
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antibody-drug Conjugates by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antibody-drug Conjugates by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Lymphoma
-
Table USA Antibody-drug Conjugates Production by Regions
-
Table USA Antibody-drug Conjugates Production Share by Regions
-
Figure USA Antibody-drug Conjugates Production Share by Regions in 2016
-
Figure USA Antibody-drug Conjugates Production Share by Regions in 2021
-
Figure USA Antibody-drug Conjugates Production Share by Regions in 2027
-
Table USA Antibody-drug Conjugates Consumption by Regions
-
Table USA Antibody-drug Conjugates Consumption Share by Regions
-
Figure USA Antibody-drug Conjugates Consumption Share by Regions in 2016
-
Figure USA Antibody-drug Conjugates Consumption Share by Regions in 2021
-
Figure USA Antibody-drug Conjugates Consumption Share by Regions in 2027
-
Table West USA Antibody-drug Conjugates Consumption by Types from 2016 to 2027
-
Table West USA Antibody-drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure West USA Antibody-drug Conjugates Consumption Share by Types in 2016
-
Figure West USA Antibody-drug Conjugates Consumption Share by Types in 2021
-
Figure West USA Antibody-drug Conjugates Consumption Share by Types in 2027
-
Table West USA Antibody-drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table West USA Antibody-drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antibody-drug Conjugates Consumption Share by End-Users in 2016
-
Figure West USA Antibody-drug Conjugates Consumption Share by End-Users in 2021
-
Figure West USA Antibody-drug Conjugates Consumption Share by End-Users in 2027
-
Table South USA Antibody-drug Conjugates Consumption by Types from 2016 to 2027
-
Table South USA Antibody-drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure South USA Antibody-drug Conjugates Consumption Share by Types in 2016
-
Figure South USA Antibody-drug Conjugates Consumption Share by Types in 2021
-
Figure South USA Antibody-drug Conjugates Consumption Share by Types in 2027
-
Table South USA Antibody-drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table South USA Antibody-drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antibody-drug Conjugates Consumption Share by End-Users in 2016
-
Figure South USA Antibody-drug Conjugates Consumption Share by End-Users in 2021
-
Figure South USA Antibody-drug Conjugates Consumption Share by End-Users in 2027
-
Table Middle West USA Antibody-drug Conjugates Consumption by Types from 2016 to 2027
-
Table Middle West USA Antibody-drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antibody-drug Conjugates Consumption Share by Types in 2016
-
Figure Middle West USA Antibody-drug Conjugates Consumption Share by Types in 2021
-
Figure Middle West USA Antibody-drug Conjugates Consumption Share by Types in 2027
-
Table Middle West USA Antibody-drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antibody-drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antibody-drug Conjugates Consumption Share by End-Users in 2016
-
Figure Middle West USA Antibody-drug Conjugates Consumption Share by End-Users in 2021
-
Figure Middle West USA Antibody-drug Conjugates Consumption Share by End-Users in 2027
-
Table Northeast USA Antibody-drug Conjugates Consumption by Types from 2016 to 2027
-
Table Northeast USA Antibody-drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antibody-drug Conjugates Consumption Share by Types in 2016
-
Figure Northeast USA Antibody-drug Conjugates Consumption Share by Types in 2021
-
Figure Northeast USA Antibody-drug Conjugates Consumption Share by Types in 2027
-
Table Northeast USA Antibody-drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antibody-drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antibody-drug Conjugates Consumption Share by End-Users in 2016
-
Figure Northeast USA Antibody-drug Conjugates Consumption Share by End-Users in 2021
-
Figure Northeast USA Antibody-drug Conjugates Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Seattle Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics
-
Figure Sales and Growth Rate Analysis of Seattle Genetics
-
Figure Revenue and Market Share Analysis of Seattle Genetics
-
Table Product and Service Introduction of Seattle Genetics
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of ImmunoGen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImmunoGen
-
Figure Sales and Growth Rate Analysis of ImmunoGen
-
Figure Revenue and Market Share Analysis of ImmunoGen
-
Table Product and Service Introduction of ImmunoGen
-
